NCT00146627View on ClinicalTrials.gov

Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosomiasis

PHASE3CompletedINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

Not specified

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Trypanosomiasis, African
Interventions
DRUG

Eflornithine

DRUG

Nifurtimox

Trial Locations (4)

Unknown

MSF-Belgium; PNLTHA, Epicentre, Isangi

PNLTHA, STI, Epicentre, Katanda

PNLTHA, STI, Epicentre, Mbuyi Maji

MSF-Holland, Nkayi, RoC

Sponsors

Collaborators (1)

Epicentre
All Listed Sponsors
collaborator

Medecins Sans Frontieres, Netherlands

OTHER

collaborator

PNLTHA-DRC;

UNKNOWN

collaborator

PNLTHA-RoC

UNKNOWN

collaborator

Epicentre

OTHER

collaborator

Swiss Tropical & Public Health Institute

OTHER

collaborator

World Health Organization

OTHER

lead

Drugs for Neglected Diseases

OTHER